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Abstract
Current knowledge point to persistence of risk factors for the development of cervical 
intraepithelial neoplasia. The infection with a high-risk oncogenic Human Papillomavirus 
(HPV) subtypes, most commonly 16 and 18, is a necessary, although not sufficient, condi-
tion for development of invasive cervical cancer (ICC) and its precancerous precursor, 
cervical intra-epithelial neoplasia (CIN). It has been suggested that CIN disease severity 
and the diversity of vaginal microbiota are associated and this may determine viral per-
sistence and disease behaviour. Our work focuses on the genetic variability associated to 
the modulation of genotoxicity induced by vaginal microbiota diversity. Relatively little is 
known about the mechanisms associated with clearance or persistence of HPV infection, 
therefore we hypothesized that may be under the influence of the genetic background.
Keywords: factors of persistence, genetic variation, microbiome, onco-microbiota, 
cervical cancer
1. Introduction
The vaginal microenvironment plays an important role in reproductive health. Human 
microbiome research has shown commensal bacteria to be a major factor in both wellness 
and disease pathogenesis. Interest in the microbiome has recently expanded beyond the gut 
to include a multitude of other organ systems for which the microbiome may have health 
implications. Here, we review the role of the vaginal microbiome in health and disease, with a 
particular focus on gynecologic malignancies, specifically cervical cancer. Further research is 
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required to understand the molecular mechanisms involved in the complex role that bacterial 
communities can play in the development of cancer.
Cervical cancer is one of the most preventable cancers. However, its progression and above 
all, the progress towards prevention is often frustrating. Moreover, and despite the continu-
ously growing body of knowledge, the role of factors that affect the human papillomavirus 
(HPV) persistence are not yet fully understood.
Indeed, the oncogenic HPVs are a necessary cause of cervical cancer; however, they are not a suf-
ficient cause, being other cofactors implicated in the increase of risk. We have also to consider 
external factors to the host, such as smoking habits, nutritional and behavioural factors (number 
of partners and their characteristics, age at onset of sexual activity), hormonal therapies-sexual 
steroids (oral contraceptives and post-menopausal substitution therapy), herpes simplex infec-
tions, Chlamydia trachomatis or other sexually transmitted infectious diseases and also nonspecific 
inflammatory diseases. Genetic and immunological factors and other endogenous co-factors may 
induce initiation and progression associated with genotoxicity, mutagenicity and irreversible cell 
proliferation [1, 2].
Dysbiosis results from the disruption of equilibrium of the microbiome. Given that the vagi-
nal microbiome composition has been shown to play a role in the HPV infection and the rate 
of HPV clearance, the vaginal microbiome structure may be associated with the development 
of cervical cancer secondary to a persistent HPV infection.
Nevertheless, recent and concise data show that composition of the early-life microbiota is 
critical in the development of the immune system, and how deviations from homeostasis can 
induce disease later in life [3].
Our group has been presenting data that reflects mainly the influence of genetic, epigenetic 
and environmental including the vaginal microbiota-derived factors in the natural history of 
HPV associated lesions leading to cervical cancer as a multifactorial disease process.
In this scenario, the microbiota and its genome (microbiome) fulfils part of the natural history 
of cervical cancer. In the last years, it has been characterized HPV-genotypes profile, and bac-
terial vaginosis (BV) leading to its association with the prevalence of HSIL and progression to 
invasive cervical cancer (ICC) in adult women.
Despite the risk factors status knowledge, we may consider the need of a more proactive behaviour, 
namely, a strategy for improving the local fora with topic therapy. In this chapter, we will focus in 
the role of genetic susceptibility associated to the development of cervical cancer. Furthermore, we 
will discuss opportunities for interventions that modify the microbiome for therapeutic purpose.
2. Factors of persistence
2.1. Vaginal microbiota, HPV and co-infections
More than ever, the association of a disrupted microbiota and the increasing incidence of 
chronic human diseases have been addressed [4]. Locally, the microbiota affects the functions 
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and regulates the immunity of epithelial barrier. Therefore, the vaginal microbiome plays an 
essential role not only in health and dysbiosis, but also in modulation of immune response 
and, possible, in the carcinogenic process. Additionally, the persistence of risk factors, namely, 
HPV and other co-infections, may be associated to the disruption of these barriers [5].
The carcinogenic process in cervical cancer results in systemic and persistent damages, with 
important changes in immune checkpoints of the involved microenvironment [6]. From the 
key-players involved in this process, the microbiota influences, locally, physiological functions 
from the maintenance of barrier homeostasis to the regulation of metabolism, hematopoiesis, 
inflammation, immunity and other functions systematically [4, 7]. This barrier is supported 
by immune cells, for example, B cells, which produces IgA that helps to neutralize pathogenic 
bacteria (Figure 1) [8]. When this barrier locally fails it is created a favourable environment for 
carcinogenesis, the dysregulation of the integrity of vaginal epithelial cells will lead to more 
susceptibility for infections, causing low-grade chronic inflammation that leads to disease.
Figure 1. The presence of certain types of lactobacillus lowers pH and induces H
2
O
2
, which may contribute to the 
formation of HOCL by myeloperoxidase. CSTs IV are associated to bacterial vaginosis and the other microorganisms, 
to pre-cancerous lesions and cervical cancer. The types of groups of bacillus may be preponderant for maintaining the 
vaginal balance. Four species are most important for the balance of the vagina ecosystem: L. gasseri (II) L. crispatus (I), 
L. jensenii (V) and L. iners (III). The inter-individual genetic polymorphic variations should be integrated in a complex 
model, since a compromise vaginal microflora and inefficient genetic profile may contribute to the development of 
cervical cancer; CSTs, community state types; CSTs I, Lactobacillus crispatus; CSTs II, Lactobacillus gasseri; CSTs III, 
Lactobacillus iners; CSTs IV, Lactobacillus, Sneathia amnii and Fusobacterium; CSTs V, Lactobacillus jensenii.
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The collection of microorganisms (or microbiota) populates complex ecosystems where 
genome is called microbiome and the implications on women health, from conception to 
the next generation, has been recently discussed [9]. A healthy vaginal microbiome is appar-
ently dominated mainly by Community State Types (CST): Lactobacillus crispatus (CSTs I), 
Lactobacillus gasseri (CSTs II), Lactobacillus iners (CSTs III) and Lactobacillus jensenii (CSTs 
V), which, regulate for instance, the balance of reactive oxygen species (ROS) (Figure 1) 
[7]. Although vaginal dysbiosis presents biological plausibly by influencing host’s innate 
immune response, susceptibility to infection, and the development of cervical disease, the 
underlying cause is not yet well understood. Nevertheless, greater diversity in the vaginal 
microbiota was associated in women with HPV-positive with cervical intra-epithelial neo-
plasia (CIN) [10].
There is a strong relationship between infection with HPV, pre-neoplastic lesions and cer-
vical cancer. Moreover, the prevalence of high-risk HPV genital infection (HSIL) and cer-
vical cancer in adult women has been documented. Therefore, the determination of this 
specific environment correlated with demographic, behavioural and clinical parameters 
will contribute to a better knowledge of key-players that triggers the carcinogenic path-
ways in cervical cancer. Other different risk factors including early age at first intercourse, 
multiple sex partners and low socioeconomic status also have significant role in disease 
initiation [11].
The HPV infects only epithelial cells, firstly, throughout the basal layer of the epithelium, 
probably via microabrasions in the epithelial surface, then the viral DNA is released from 
the capsid and transported into the nucleus as free genetic material or extrachromosomal 
episomes (Figure 1) [12]. Environmental factors might locally influence the initiation of this 
invasion, among other co-factors, HPV allows potential tumour cells to escape from lactoba-
cilli-mediated control and interfering with intracellular induction of apoptosis [7].
Recently, changes from pro-inflammatory to anti-inflammatory signals - the cytokine milieu 
- may affect whether or not an infection is cleared [13] and hypothetically an environment 
favourable or not for tumour growth, might follow a change in regulation of the expression 
of pro-inflammatory cytokines. After infection takes place, the microbiome changes and its 
diversity increases. HPV proteins E2, E6 and E7 enhance IL-10 expression secondary to mac-
rophages type 2 presence. These latter are also enhanced in its activity by TGFβ-1 in cytokines 
expression and its phagocytic efficacy, which is in turn stimulated by the microbiota present. 
The increase of diversity in the microbiota, through its toxins (FadA from Fusobacterium spp.) 
will promote a metastasis phenotype similar to what happens in cervical cancer [13].
Moreover, polymorphic genetic variants used as surrogate markers might explain the inter-
individual variations and the differential immune response causing the persistence and the 
progression of HPV effects. We had studied some polymorphisms that are associated with 
genetic susceptibility to cervical infection and increase for risk of acquiring and transmitting 
HPV infection. These polymorphisms are involved in several pathways, throughout the pro-
duction of metabolites or other carcinogenic substances, by increasing the susceptibility of the 
inflamed epithelium or by changing the immune system equilibrium (Figure 1).
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2.2. Lactobacilli enhance reactive oxygen species and the role of genetic 
susceptibility in the vaginal microbiome
The ROS, comprise a group of oxygen derivatives from distinct oxidation status of O
2
, such 
as, superoxide radical anion (O
2
.−), and hydroxyl free-radical (OH.−) and as well as non-radical 
forms, namely H
2
O
2
 [14]. The latter has a role as a second messenger molecule in signalling 
cascades that regulates gene expression and fundamental cellular processes such as prolif-
eration, differentiation and migration [15]. Lactobacilli’s H
2
O
2
 production in the absence of 
peroxidase may result in toxic concentrations of H
2
O
2
 and cause damage of the mucosa [16]. 
The presence of peroxidases guarantees the generating of hypochlorous acid (HOCL) in the 
vagina inducing a steady removal of excess of H
2
O
2
 and generation of HOCL [17].
H
2
O
2
-producing lactobacilli strains, use a NADH oxidase that directly generates H
2
O
2
 in 
a two-electron reduction of O
2
 (Figure 1). Klebanoff et al. proposed that hydrogen perox-
ide H
2
O
2
, product of lactobacilli and peroxidase, in the vagina of healthy women might 
be responsible for the prevention of vaginosis and also might exert an antitumour effect 
[18]. The antimicrobial effect of H
2
O
2
-generating lactobacilli is efficiently enhanced in the 
presence of peroxidases (such as myeloperoxidase and eosinophil peroxidase) and halides 
[18]. This points to a role of HOCL as superior antimicrobial compound. The vaginal fluid 
of the majority of healthy women contains sufficiently high concentration of peroxidase 
to allow biologically significant HOCL synthesis in the presence of H
2
O
2
-generating lac-
tobacilli [18].
Bauer proposed that peroxidase, which converts H
2
O
2
 into HOCL, is responsible for cre-
ating a microbicial vaginal milieu by maintaining a balanced, non-toxic [18]. The papers 
of Bauer had highlighted the role of lactobacilli in the vaginal flora of healthy premeno-
pausal women pointing to the beneficial effects for the predominance of microorganisms. 
Lactobacilli adhere to epithelial cells and thus cause sterile prevention of cell infections with 
undesirable microorganisms. Lactobacilli cause low pH through production of lactate and 
also release bactericidal compounds (Figure 1) [7]. Others ROS are the highly reactive and 
toxic by-products of oxygen metabolism, which can damage bacterial nucleic acids, proteins 
and cell membranes [19].
Recent work of Kruger and Baeur 2017, confirms that the lactobacillus-derived H
2
O
2
 per se is 
not likely to be beneficial for the vaginal epithelium, because it causes nonselective lesions in 
nontransformed as well as transformed cells. The combination of lactobacillus and peroxidase 
is more favourable. Moreover, the lactobacilli in this system can be completely mimicked 
in vitro by H
2
O
2
 generated by glucose oxidase, indicating that its contribution for potential 
tumour prevention is fully explained by bacterial generation of H
2
O
2
 [17].
This idyllic scenario is considered for normal cells or untransformed cells, which have a wide 
antioxidant regulatory defence system that serves to prevent the oxidative stress and the 
development of neoplasms [20]. Nevertheless, the papillomavirus infected cells (in particular 
by oncogenic types HPV 16, 33, 31) are resistant to this pathway of apoptosis induction. In 
transformed cells caused by damages induced by HPV, cells lose control of senescence and 
p53 activity is abrogated [21].
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The combination of the host genome and microbiome increases genetic variation and pheno-
typic plasticity, enabling the holobiont to increase its overall fitness [22]. Genome-wide asso-
ciation studies identified cervical cancer susceptibility variants across different populations 
[23]. Therefore, the input of these and other polymorphic variants, may reflect the interindi-
viduality of response in women with cervical cancer. In this chapter, we will focus on some 
these polymorphisms involved in the modulation of ROS production.
2.2.1. NAD(P)H oxidase (NOX)
The production of O
2
.− through NAD(P)H oxidase (NOX) by transformed cells or cervical can-
cer cells, can be specifically targeted with production of OH− that induces apoptosis of these 
cells. The spontaneous dismutation of superoxide anions produce H
2
O
2
, at low pH, causes 
mutagenic effects that initiate malignant transformation (Figure 1). The high local concen-
trations of ROS through expression of SOD and catalase, it has also the potential to prevent 
elimination of transformed cells trough ROS/Reactive Nitrogen Species (RNS)-dependent 
intercellular apoptosis-inducing signalling [14].
The changes in the gut influences the vaginal microbiome, for instance the expression of NOX 
is modulated by, for example, the presence of Helicobacter pylori, which induces an indirect 
prooxidative mechanism through recruitment of neutrophils and by assembling of their 
NOX2 components to the cell membrane [1, 24].
NOX are membrane-associated oligomeric proteins that produce O
2
· for host defence and 
other functions. Generation of extracellular O
2
· through NOX is associated with oncogene 
activation and seems to be required for the control of cell proliferation and maintenance of the 
transformed state [25]. This protein consists of among other peptides by a regulatory 22-kDa 
α- subunit (p22phox) and a 91-kDa catalytic β-subunit (gp91phox). The p22phox protein is the 
NOX element responsible for the regulation of electron transfer to gp91phox [26]. The p22phox 
(CYBA gene) polymorphism with rs4673 (C-242 T) causes a functional non-conservative sub-
stitution from histidine-72 to a tyrosine residue that decreases its activity [27] (Figure 1). Our 
previous work unravels the association between CYBA polymorphism in women with ICC, 
having been observed a heterosis phenomenon with a protective profile in ICC [14]. This 
U type curve reflects, on one hand, the homozygote genotype CC leaded to increased ROS 
production, mainly H
2
O
2
 resulting from dismutation of O2·, which in turn results in exces-
sive cell growth; on the other hand, the homozygote genotype TT lowers ROS production, 
mainly decreasing O2· mediated apoptosis cell capacity, resulting in a higher risk for the 
development of tumours in both cases [14]. Updated data from our cohort, we found that the 
TT genotype of ph22phox polymorphism was a tendency for increased risk in ICC (Figure 1) 
(OR = 3.57, 95% [0.85–13.48], P = 0.057), being age and smoking habits dependent factors.
Women with cervical cancer will have a lower induction of O2· and, consequently, compromis-
ing the dismutation by SOD3 of this apoptotic factor into H
2
O
2
. The continuous modification 
of vaginal microbiota throughout depletion of lactobacillus or infections with HPV, contribute 
to increase of pH, influencing the concentrations of ROS in vaginal milieu. Moreover, women 
with TT genotype of p22phox polymorphisms will have a worse response to these important 
modifications (Figure 1).
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2.2.2. Catalase
The NOX and catalase (CAT) proteins work in sequence in a metabolic pathway. Transformed 
cells, spontaneous and enzymatic dismutated O
2
− into H
2
O
2
 by SOD occurs at right density 
to allow optimal velocity of the ROS interactions [28]. The CAT is a heme enzyme that plays 
a predominant role in controlling H
2
O
2
 and O2· protecting in this way cells from deleterious 
effects of oxidative stress. In healthy women, this protector effect rises from the conversion of 
H
2
O
2
 into H
2
O and O
2,
 but in cervical cancer transformed cells, the ROS signalling is inhibited 
by a membrane associated catalase and causing control system failure that ultimately results 
in cell apoptosis failure [26, 29]. Notwithstanding, women with a genetic variant of CAT asso-
ciated with a decrease activity will not contribute to this control system (Figure 1).
In humans, the CAT gene is located on chromosome 11p13 and its rs1001179 polymorphism 
(C-262 T) is located on the promoter region and influences transcription and consequent 
expression of this enzyme and hence the oxidative status of cells and its microenvironment 
[30]. In a case–control study, we observed a greater risk for developing ICC associated with 
the homozygote genotype TT of CAT polymorphism C-262 T polymorphism of the CAT gene 
(OR = 3.03, 95% CI 1.46–6.29, P = 0.003) [31]. Similarly to other cancers types, the T variant of 
this polymorphism is associated to a decreased enzyme activity, generating high levels of 
ROS [32–34]. The interaction of CC genotype of p22phox polymorphism and the TT genotype 
of CAT leads to a higher risk for ICC (OR = 3.95, 95% CI 1.07–14.52, P = 0.032) [31].
Moreover, recent reports have suggested a connection between oestrogen exposure, CAT 
activity and polymorphism in breast cancer [35]. These findings suggest that CAT genotype 
modifies the effect of hormone replacement therapy (HRT) use on breast cancer risk and that 
HRT may affect risk by affecting oxidative stress. This scenario, also might be important in 
cervical cancer, namely, women with CAT TT genotype (associated to a decreased catalase 
activity), will deficiently protects cells from ROS.
2.2.3. Myeloperoxidase
The oxidative stress conditions are generated by the release of ROS at the infection site by 
host immune cells such as neutrophils and monocytes. Additionally, resistance of oncogenic 
papilloma virus-expressing cells to apoptosis induction by the HOCL/hydroxyl anion path-
ways is likely, as papilloma virus-containing cells are also resistant to intercellular induction 
of apoptosis [36].
The toxic concentrations of H
2
O
2
 could be converted by myeloperoxidase (MPO). MPO, a 
lysosomal enzyme expressed in polymorphonuclear neutrophils, has the potential to kill HPV 
transformed cells, as a component of an intercellular induced-apoptosis pathway. The MPO 
was also being pointed as a key-player on controlling of vaginal microenvironment, namely, 
the H
2
O
2
-generating Lactobacillus acidophilus. In healthy women, this production inhibits the 
overgrowth of potentially pathogenic organisms; in fact, it can be toxic to other bacteria, 
fungi, viruses, spermatozoa, or tumour cells [37].
Supposedly, there are no resident neutrophils and macrophages on vaginal microenviron-
ment, nevertheless the persistence of risk co-factors and ROS may lead to the recruitment of 
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inflammatory cells. The presence of MPO on vaginal milieu is activated. Probably, the persis-
tence of death cells recalls of neutrophils to vagina, being MPO important for the control of 
excess production of HOCl. In the vaginal microenvironment, the MPO catalyzes the reaction 
between H
2
O
2
 and either thiocyanate ions or a halide, such as iodide, bromide or chloride 
ions, yielding HOCl, which participates in the oxidative burst during the innate host defence 
[38]. MPO may act in synergy with other proteins. Therefore, an imbalance between oxidants/
antioxidants could mean a higher chance for mutations and oncogenesis leading to diseases, 
including cancer—since MPO produces ROS secondary derivatives can be involved in the 
neoplastic transformation of cells through this pathway.
H
2
O
2
, and a halide form a powerful antimicrobial system in phagocytes and tissue fluids, 
which certain microorganisms can serve as the source of H
2
O
2
 for this system. The equilibrium 
of the production of H
2
O
2
 by Lactobacilli in the vagina appears to be a nonspecific host defence 
mechanism, which can be potentiated by myeloperoxidase that produces HOCl (Figure 1).
The production of superoxide through NADPH oxidase from cervical cancer cells, can be spe-
cifically targeted with production of OH− radicals that induces selective apoptosis of these cells 
[16].
The polymorphism in the MPO gene induce a transition G463A (rs2333227), in the promotor 
region of the gene, where the wild-type G allele promotes the binding of transcription factors 
leading to a higher transcriptional activity than the A allele [39].
We found that women with the GG genotype had lower risk for cervical cancer than the 
women who displayed the heterozygous genotype GA (OR = 0.546, 95% CI = 0.315–0.939, 
P = 0.028, OR = 2.210, 95% CI [1.257–3.886], p = 0.008, respectively). The genotype that leads 
to a higher concentration of ROS (GG) presents itself as a protection factor in comparison to 
the homozygous genotype (AA) [39]. Moreover, recently, we observed that the A carriers of 
MPO polymorphism were about 5-fold of increased risk for cervical cancer (OR = 5.41, 95% 
CI [2.15–13.64], P < 0.0001) (Figure 1), being dependent of age (OR = 3.38, 95% CI [0.85–13.48], 
P = 0.085) and independent of smoking habits (OR = 3.85, 95% CI [1.33–11.11], P = 0.013). The 
interaction of HOCl and superoxide of transformed cells will generate apoptosis-inducing 
hydroxyl radicals.
We suggest that there is an association between the H
2
O
2
-producing strains found in the vagi-
nal microbial flora and high activity of MPO leading to a clearance of the HPV-infected cells, 
the relation may also lead to the apoptosis of the transformed cells, producing O2. and OH., 
acting as a protective factor for a cervical cancer [16, 17, 26].
2.2.4. Reactive nitrogen species
Nitric oxide is generated by nitric oxide synthase (NOS) and presents 3 isoforms: neuronal 
(NOS1), endothelial (NOS3) and inducible (NOS2). High local concentrations of ROS through 
expression of SOD and catalase might be associated to prevention of elimination of trans-
formed cells trough ROS/RNS-dependent intercellular apoptosis-inducing signalling [14, 16]. 
Conversely the excess of NO inhibits the apoptosis induction associated to H
2
O
2
 and reversely 
NO-mediated apoptosis induction was inhibited by excess of H
2
O
2
 [29].
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The NOS3 gene is located in the 7q35–36 region of chromosome 7 and the genetic polymorphism 
with a great clinical relevance is the 27 bp-VNTR 4b/a intron 4 [40]. In addition, NO produced 
by endothelial and epithelial cells, also modulates the regulation of vascular endothelial growth 
factor and is possibly associated to increase in processes of invasiveness and metastasis [41]. 
Preliminary results from our group, although only with a trend, identify that the A variant of 
NOS3 polymorphism, which is associated with higher activity of this enzyme, predisposes to 
ICC OR = 7.50, 95%CI [0.88–63.9], P = 0.066).
2.2.5. Catechoestrogens and cytochrome P450 (CYP1A1)
There is a clear association between the excessive and cumulative exposure to oestrogens and 
the development of cancer in hormone-sensitive tissues, such as the cervix. Therefore, we found 
that CYP1A1 and Catechol-o-methyltransferase (COMT) work in a metabolic sequence and 
their interaction could lead to an alternative pathway of oestrogen metabolism with production 
of 16-OH-estrone that is more proliferative and less apoptotic [42, 43]. The role of oestrogen 
and the association of CSTs favourable for balance vaginal milieu, was previously debated [44].
Aryl hydroxylase (AhR) the transcription factor of CYP1A1 is also associated with immuno-
suppression after activation of IL-22 pathway, and the maintenance of intraepithelial in innate 
lymphocytes leading to the mucosal protection from inflammation [45].
Recently, a very interesting work unlighted the mechanism, where the Lactobacillus-derived H
2
O
2
 
suppress host kynurenine metabolism, by inhibiting the expression of the metabolizing enzyme, 
indoleamine 2,3-dioxygenase (IDO1), in the intestine [46]. Moreover, maintaining elevated kyn-
urenine levels during Lactobacillus supplementation diminished the treatment benefits.
3. Treatment and prevention: microbiota-derived factors
Finally, as suggested by other authors, it may be possible to expand the use of probiotics in 
the treatment of gynecologic cancers. The study of the role of probiotic bacteria for the pre-
vention of colon and cervical cancer has led to the conclusion the tumour preventive effects of 
probiotic bacteria might be due to their control of the microbial flora, establishment of benefi-
cial metabolic effects and stimulation of the immune system [37, 47]. Therefore, we can act in 
the prevention, specifically, the relapses.
Genetic analysis based on single nucleotide polymorphisms identified genetic variants associ-
ated with tumour rejection in mice, which could potentially affect ROS production and NK cell 
activity. That results also supports that B cells play a detrimental role in antitumour immunity 
and suggest that targeting B cells could enhance the antitumour response and improve the 
efficacy of therapeutic cancer vaccines [8].
The conventional photon radiotherapy for cervical cancer irradiates parts of the healthy tissue. 
This treatment perturbs the vaginal microbiome and disrupt the epithelial barrier function, 
permitting translocation of pathogenic bacteria and causing an inflammatory response [48]. 
The role of probiotic bacteria for the prevention of colon cancer has led to conclusion of the 
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tumour preventive potential by the microbes. Additionally, the genetic polymorphism might 
be related to genetic susceptibility to infections and so, the implementations of probiotics may 
reinforce the immune system. A better understanding of this line will allow for the develop-
ment of therapies that can manipulate the microbiome to reinstate homeostasis.
The application of probiotic strains Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 
concomitantly with specific anti-infective agents provides more reliable cytological diagnos-
tics, reduces the number of false positive and false negative findings on cervical malignancy 
and normalizes vaginal microflora in higher percentage of patients with vaginal infections 
compared with therapy including anti-infective agents only [49].
The use of probiotics, such as L. acidophilus, concomitant with the subsequent use of antibi-
otics, helps to restore the natural bacteria in the digestive tract that eventually are killed by 
antibiotics.
Recently, due to changes in the sexual behaviour of the general population, especially in 
developed countries, there has been an increase in the incidence of HPV infection in other 
parts of the body, including oropharynx and anus, among others.
In summary, a personalized clinical / therapeutic approach is suggested to avoid unnecessary 
treatments, based on previous history (onset of sexual activity, number of partners, anovula-
tory, parity, nutrition, alcohol, tobacco, genetics-immunity, etc.), in vaginal pH, Lactobacillus, 
in the diagnosis of HPV, viral load, mRNA, HSV, CMV, HSIL, AGC, CINI and CINII / III. 
Chlamydia trachomatis, Mycoplasma, Ureaplasma, Neisseria gonorrhoeae) and in the immunohisto-
chemical study (p16 and Ki-67) of dysplasia [50, 51].
4. Conclusions
The HPV is not a sufficient cause for developing of cervical cancer, therefore other factors may 
be involved in this susceptibility, namely the microenvironment in vagina and inter-individ-
ual genetic polymorphic variations. These variables must be integrated in a complex model 
that integrates other co-factors, such as, smoking, diet and oral contraceptives. According to 
this review based on recent data, it seems that a deficiency of an antioxidant mechanism asso-
ciated to a compromise vaginal microflora and inefficient genetic profile may contribute to 
the development of cervical cancer. We hypothesis that the genetic background and dysbiosis 
may contribute to increase risk for gynecologic advanced cancer.
Therefore, the equilibrium of gut/vaginal microbiota and adequate supplementation for a 
homeostasis of oxidant and antioxidant species may contribute to the regression of the persis-
tence of factors associated with cervical cancer.
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